针对亨廷顿病的自-溶解体通路:一个药理学视角
Junsheng Yang1, Chaoyue Zhang1
1Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
Frontiers in aging neuroscience
|June 12, 2023
概括
准自-溶酶体通路 (ALP) 对亨廷顿病有希望.
科学领域:
- 细胞生物学 细胞生物学
- 神经退行性疾病 神经退行性疾病
- 分子医学是分子医学.
背景情况:
- 自-溶酶体通路 (ALP) 清除细胞内蛋白质聚合物.
- 亨廷顿病 (HD) 涉及容易聚合的蛋白质,使ALP成为潜在的治疗点.
- 自复杂性和HD细胞中的缺陷对ALP向治疗提出了挑战.
研究的目的:
- 总结当前针对阿尔巴巴治疗疾病治疗的挑战.
- 讨论最近在食和向蛋白质降解方面的发现.
- 通过ALP识别HD治疗的新目标和策略.
主要方法:
- 关于ALP和亨廷顿病的当前研究的文献综述.
- 对调节自的挑战进行分析,以获得治疗效益.
- 综合了近期关于农和向蛋白质降解的研究结果.
主要成果:
- 针对亨廷顿病的ALP是药理学上复杂的.
- 自缺陷存在于亨廷顿病细胞中.
- 最近的进展为食和蛋白质降解提供了新的见解.
结论:
- 尽管面临挑战,ALP仍然是亨廷顿病治疗开发的关键领域.
- 专注于农和向蛋白质降解的新型策略正在出现.
- 对ALP调节的进一步研究可能会为亨廷顿病提供有效的治疗方法.
相关概念视频
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Autophagy
4.4K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
The Proteasome
913
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
913


